Cargando…

Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer

BACKGROUND: This study evaluates the geographic expression pattern of Raf-1 Kinase Inhibitor Protein (RKIP) in colorectal cancer (CRC) in correlation with clinicopathological and molecular features, markers of epithelial-mesenchymal transition (EMT) and survival outcome. METHODS: Whole-tissue sectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koelzer, V H, Karamitopoulou, E, Dawson, H, Kondi-Pafiti, A, Zlobec, I, Lugli, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670488/ https://www.ncbi.nlm.nih.gov/pubmed/23632477 http://dx.doi.org/10.1038/bjc.2013.197

Ejemplares similares

Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)
por: Karamitopoulou, Eva, et al.
Publicado: (2013)

Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients
por: Zlobec, I, et al.
Publicado: (2014)

Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
por: Galván, J A, et al.
Publicado: (2015)

CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer
por: Lugli, A, et al.
Publicado: (2009)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy
por: Zlobec, I, et al.
Publicado: (2007)

Two-marker protein profile predicts poor prognosis in patients with early rectal cancer
por: Zlobec, I, et al.
Publicado: (2008)

Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy
por: Zlobec, I, et al.
Publicado: (2008)

Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancer
por: Sokol, Lena, et al.
Publicado: (2015)

Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study
por: Koelzer, Viktor H, et al.
Publicado: (2015)

Tumour budding: a promising parameter in colorectal cancer
por: Lugli, A, et al.
Publicado: (2012)

Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer
por: Rogers, A C, et al.
Publicado: (2016)

Prognostic relevance of Tiam1 protein expression in prostate carcinomas
por: Engers, R, et al.
Publicado: (2006)

Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant
por: Molinari, F, et al.
Publicado: (2009)

A short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation
por: Weiswald, L-B, et al.
Publicado: (2013)

pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant
por: Brunner, A, et al.
Publicado: (2012)

Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer
por: Ngan, C Y, et al.
Publicado: (2007)

Expression of oestrogen receptor β and prognosis of colorectal cancer
por: Rudolph, A, et al.
Publicado: (2012)

Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer
por: Milde-Langosch, K, et al.
Publicado: (2005)

Expression and prognostic value of transcription factor PROX1 in colorectal cancer
por: Skog, M, et al.
Publicado: (2011)

TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer
por: Galván, José A., et al.
Publicado: (2014)

The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance
por: Alnabulsi, Abdo, et al.
Publicado: (2017)

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
por: Goos, J A C M, et al.
Publicado: (2013)

Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential?
por: McLean, M H, et al.
Publicado: (2013)

Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer
por: Goossens-Beumer, I J, et al.
Publicado: (2014)

Expression of SDF-1α and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer
por: Yoshitake, N, et al.
Publicado: (2008)

Characterisation and protein expression profiling of annexins in colorectal cancer
por: Duncan, R, et al.
Publicado: (2008)

Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma
por: Kontos, C K, et al.
Publicado: (2010)

Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
por: Ferdinande, L, et al.
Publicado: (2012)

FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role
por: Bullock, M D, et al.
Publicado: (2013)

Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival
por: Herath, N I, et al.
Publicado: (2009)

Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer
por: Dawson, Heather, et al.
Publicado: (2013)

Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival
por: Hanly, A M, et al.
Publicado: (2006)

Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purification
por: Smith, M J, et al.
Publicado: (2009)

Differential expression of DHHC9 in microsatellite stable and instable human colorectal cancer subgroups
por: Mansilla, F, et al.
Publicado: (2007)

PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients
por: Frattini, M, et al.
Publicado: (2007)

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer
por: Cihoric, N, et al.
Publicado: (2014)

BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcome
por: Saridaki, Z, et al.
Publicado: (2010)

Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases
por: Mole, D J, et al.
Publicado: (2011)

Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours
por: Linton, K M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_42dmi0bip2tg72i570725qnh9n